21
Feb

A European Medicines Agency committee has recommended approval for another COPD treatment from GlaxoSmithKline, setting the stage for a likely nod in the coming months as the drugmaker looks to bolster its respiratory franchise.

…read more

Source: EU breathes hope into GlaxoSmithKline’s latest respiratory contender

    

0 No comments